Mahindra & Mahindra Financial Services Ltd (M&MFIN) Q1 FY27 Results Analysis: PAT Surges 70%, Asset Quality at Multi-Year Best

CompoundingAI Research Updated July 21, 2026 2 min read

Mahindra & Mahindra Financial Services Ltd reported Q1 FY27 numbers with revenue of Rs. 4,972.12 Cr (+12.50% YoY) and PAT growth of +69.70% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 21, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 4,972.12 Cr (+12.50% YoY)
PAT (Q1)Rs. 898.65 Cr (+69.70% YoY)
EPS (Q1)Rs. 6.47 (+59.00% YoY)
Market capRs. 48,620.60 Cr
CMPRs. 349.85

Quarter Snapshot

M&MFIN reported a strong Q1 with PAT nearly doubling (+69.7% YoY) driven by NII expansion, operating leverage, and a sharp decline in credit costs. Asset quality improved significantly with Stage-3 and PCR at multi-year best levels, while disbursements grew 21% YoY, exceeding the steady-state guidance. The only caution is AUM growth trailing the 16-18% CAGR target, but the trajectory remains on track.

Key Investment Insights

Key Positives

  • Standalone PAT grew 69.7% YoY to Rs 898.65 Cr, driven by NII expansion (+19.9% YoY) and impairment decline (-13.6% YoY).
  • PPOP grew 29.8% YoY to Rs 1,755.93 Cr, the strongest growth in recent quarters.
  • Cost-to-income ratio improved 377 bps YoY to 35.75%, reflecting operating leverage.
  • Asset quality improved: Gross Stage-3 at 3.45% (down 40 bps YoY), Net Stage-3 at 1.48% (down 43 bps), PCR at 58.08% (up 665 bps).
  • Disbursements grew 21% YoY to approximately Rs 15,560 Cr, exceeding the 15%+ CAGR guidance.
  • Net profit margin expanded 614 bps YoY to 18.07%.

Risk Factors

  • AUM growth of 12% YoY trails the company's 16-18% CAGR target.
  • Debt/equity ratio increased to 5.00x from 4.75x YoY, indicating higher leverage.
  • Capital adequacy ratio declined to 18.54% from 20.62% YoY.
  • Others segment (insurance, AMC) saw margin compression from 24.96% to 14.34% YoY, with segment result down 29.5%.
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now